Charles Schwab Q1 2026 13F Holdings and Activity Report

I. Institutional Overview

The institutional investment landscape is often defined by the movements of "mega-managers," and few entities command as much market presence as Charles Schwab. As of the portfolio snapshot dated March 31, 2026, Charles Schwab manages a staggering total portfolio market value of approximately $654.44 billion. This scale places the institution in the upper echelon of global asset managers, functioning not merely as a participant in the financial markets but as a significant structural component of the market itself. To understand the investment logic of such a massive entity, one must look beyond individual stock picks and analyze the broader strategic positioning that a portfolio of this magnitude requires.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

II. Sector Allocation Analysis

At nearly 27% of the portfolio, Technology is the undisputed anchor of the institution's strategy. This allocation reflects a belief in the "permanence of growth" within the tech sector. By holding such a significant weight in technology, the institution is essentially betting on the continued expansion of software-as-a-service, semiconductor innovation, and cloud computing. However, the internal movements this quarter suggest a shift from speculative growth toward "Big Tech" platforms that possess fortress balance sheets and dominant market positions. This is a move toward "defensive growth"—seeking companies that can grow even in a high-interest-rate environment.

Based on this allocation, we can infer that Charles Schwab's investment committee views the current macroeconomic environment as one of "cautious expansion." The heavy tech weight shows they are not afraid of growth, but the significant allocations to Financials, Healthcare, and Staples show they are deeply aware of the risks of inflation and market volatility. They are positioned to benefit from a "soft landing" scenario where growth continues at a moderate pace, but they are sufficiently diversified to survive a period of stagnation. This is the allocation of an institution that values "certainty of survival" as much as "opportunity for growth."

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

III. Top 10 Holdings Deep Dive

NVIDIA remains the crown jewel of the portfolio, with a market value exceeding $28 billion. This is a "conviction holding" in every sense of the word. Despite the stock's meteoric rise in recent years, the institution chose to add 3.07% to its position this quarter. This move is particularly telling because the portfolio weight actually decreased slightly (from 4.52% to 4.28%), which indicates that the addition of shares was an active attempt to maintain a dominant position even as other parts of the portfolio grew or as the broader market fluctuated. The logic here is clear: NVIDIA is viewed as the fundamental infrastructure provider for the artificial intelligence era. By increasing its share count, the institution is signaling that it believes the AI cycle is still in its mid-stages, with significant runway remaining for data center expansion and enterprise AI integration. This is not a trading position; it is a strategic bet on the foundational technology of the 21st century.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

IV. Major Buys/Additions

The most significant move this quarter was the staggering 146.65% increase in the position of UnitedHealth Group. By adding over 12 million shares with an estimated value of $3.35 billion, the institution has more than doubled its commitment to the managed healthcare giant. This is a classic "defensive clustering" move. UnitedHealth is the dominant player in the U.S. healthcare system, benefiting from both the private insurance market and the massive expansion of government-sponsored programs like Medicare Advantage. The motivation here is likely "valuation trough mining" combined with a search for certainty. Healthcare stocks often trade at a discount during periods of regulatory uncertainty, and Charles Schwab seems to be using this as an opportunity to build a massive core position in a company with incredibly stable cash flows and a wide competitive moat.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

V. Major Sells and Exits

The most dramatic reduction this quarter was the 51.80% cut in Cisco Systems, realizing an estimated $2.83 billion. This is a "Major Strategic Contraction." Cisco has long been a staple of institutional portfolios as a reliable, dividend-paying tech giant. However, the decision to slash the position by half suggests a fundamental shift in confidence regarding the company's growth prospects in a cloud-native world. As networking moves toward software-defined models and hyperscalers build their own hardware, legacy providers like Cisco face significant headwinds. This reduction is likely an "active rebalancing" away from "old tech" to fund the "new tech" infrastructure plays like Qualcomm and Accenture mentioned in the previous section.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

VI. Investment Insights and Risk Warnings

The logic chain is clear: 1. Sold what: Legacy technology (Cisco), patent-challenged healthcare (AbbVie), and regional banking (Comerica). 2. Why sell: These assets represent "yesterday's winners" or carry high idiosyncratic risks that are no longer compensated by their potential returns. 3. Bought what: Systemic healthcare leaders (UnitedHealth, Abbott), defensive consumer staples (Procter & Gamble), and "applied" technology infrastructure (Qualcomm, Accenture). 4. Why buy: These companies offer "Quality Certainty"—they have the scale, pricing power, and essential nature required to generate consistent cash flows regardless of the macroeconomic environment. 5. Overall portfolio change: The portfolio has become more "barbelled." It maintains its massive growth engine in "Big Tech" (NVIDIA, Apple, Microsoft) but has significantly strengthened its "defensive floor" through multi-billion-dollar additions in healthcare and staples.

This section shows only part of the complete report. View the app for the full analysis, position-level detail, and quarter-over-quarter tracking.

Sources and limitations

This report uses public U.S. Securities and Exchange Commission Form 13F disclosures and structured data maintained by 13F Hub. A 13F filing is a quarter-end snapshot of reportable long positions, is normally published with a delay, and does not disclose every short position, cash balance, bond, derivative, or non-U.S. asset.

Narrative content is prepared from the same-period SEC disclosure and 13F Hub structured data, then checked before publication. This material is for research and education, not personalized investment advice.